Schrumpf E - Search Results

1

Update on primary sclerosing cholangitis.

Karlsen TH, Schrumpf E, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. Dig Liver Dis. 2010 Jun;42(6):390-400. doi: 10.1016/j.dld.2010.01.011. Epub 2010 Feb 20. Dig Liver Dis. 2010. PMID: 20172772 Review.

2

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.

Boberg KM, Rocca G, Egeland T, Bergquist A, Broomé U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Among authors: schrumpf e. Hepatology. 2002 Mar;35(3):652-7. doi: 10.1053/jhep.2002.31872. Hepatology. 2002. PMID: 11870380

3

Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation.

Boberg KM, Jebsen P, Clausen OP, Aabakken L, Brekke I, Schrumpf E. Boberg KM, et al. Among authors: schrumpf e. J Hepatol. 2003 Sep;39(3):453. doi: 10.1016/s0168-8278(03)00326-x. J Hepatol. 2003. PMID: 12927935 No abstract available.

4

Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.

Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM; IBSEN Study Group. Wiencke K, et al. Among authors: schrumpf e. J Hepatol. 2004 Aug;41(2):209-14. doi: 10.1016/j.jhep.2004.04.024. J Hepatol. 2004. PMID: 15288468

5

Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis.

Berstad AE, Aabakken L, Smith HJ, Aasen S, Boberg KM, Schrumpf E. Berstad AE, et al. Among authors: schrumpf e. Clin Gastroenterol Hepatol. 2006 Apr;4(4):514-20. doi: 10.1016/j.cgh.2005.10.007. Clin Gastroenterol Hepatol. 2006. PMID: 16616358 Clinical Trial.

6

No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.

Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A. Wiencke K, et al. Among authors: schrumpf e. Scand J Gastroenterol. 2006 May;41(5):586-91. doi: 10.1080/00365520500377870. Scand J Gastroenterol. 2006. PMID: 16638702

7

Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.

Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E. Boberg KM, et al. Among authors: schrumpf e. J Hepatol. 2006 Oct;45(4):568-74. doi: 10.1016/j.jhep.2006.05.010. Epub 2006 Jun 21. J Hepatol. 2006. PMID: 16879890 Clinical Trial.

8

Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.

Karlsen TH, Lie BA, Frey Frøslie K, Thorsby E, Broomé U, Schrumpf E, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. Gastroenterology. 2006 Sep;131(3):781-7. doi: 10.1053/j.gastro.2006.05.057. Gastroenterology. 2006. PMID: 16952547

9

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Karlsen TH, et al. Among authors: schrumpf e. Am J Gastroenterol. 2007 Jan;102(1):115-21. doi: 10.1111/j.1572-0241.2006.00928.x. Epub 2006 Nov 13. Am J Gastroenterol. 2007. PMID: 17100974

10

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. Karlsen TH, et al. Among authors: schrumpf e. J Hepatol. 2007 May;46(5):899-906. doi: 10.1016/j.jhep.2007.01.032. Epub 2007 Feb 27. J Hepatol. 2007. PMID: 17383044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters